|
1
|
Ferguson LR and Laing WA: Chronic
inflammation, mutation and human disease. Mutat Res. 690:1–2. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dinarello CA: Inflammation in human
disease: anticytokine therapy. Biol Blood Marrow Transplant.
15(Suppl 1): 134–136. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hayden MS and Ghosh S: Signaling to
NF-kappaB. Genes Dev. 18:2195–2224. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Aradhya S and Nelson DL: NF-kappaB
signaling and human disease. Curr Opin Genet Dev. 11:300–306. 2001.
View Article : Google Scholar
|
|
5
|
Campbell KJ and Perkins ND:
Post-translational modification of RelA (p65) NF-kappaB. Biochem
Soc Trans. 32:1087–1089. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen LF, Mu Y and Greene WC: Acetylation
of RelA at discrete sites regulates distinct nuclear functions of
NF-kappaB. EMBO J. 21:6539–6548. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen LF, Fischle W, Verdin E and Greene
WC: Duration of nuclear NF-kappaB action regulated by reversible
acetylation. Science. 293:1653–1657. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen LF and Greene WC: Shaping the nuclear
action of NF-kappaB. Nat Rev Mol Cell Biol. 5:392–401. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Greene WC and Chen LF: Regulation of
NF-kappaB action by reversible acetylation. Novartis Found Symp.
259:208–217. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim MJ, Seong AR, Yoo JY, et al: Gallic
acid, a histone acetyltransferase inhibitor, suppresses
beta-amyloid neurotoxicity by inhibiting microglial-mediated
neuroinflammation. Mol Nutr Food Res. 55:1798–1808. 2011.
View Article : Google Scholar
|
|
11
|
Seong AR, Yoo JY, Choi K, et al:
Delphinidin, a specific inhibitor of histone acetyltransferase,
suppresses inflammatory signaling via prevention of NF-κB
acetylation in fibroblast-like synoviocyte MH7A cells. Biochem
Biophys Res Commun. 410:581–586. 2011.PubMed/NCBI
|
|
12
|
Choi KC, Jung MG, Lee YH, et al:
Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor,
inhibits EBV-induced B lymphocyte transformation via suppression of
RelA acetylation. Cancer Res. 69:583–592. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Holmes C: Systemic inflammation and
Alzheimer’s Disease. Neuropathol Appl Neurobiol. 39:51–68.
2012.
|
|
14
|
Cameron B and Landreth GE: Inflammation,
microglia, and Alzheimer’s disease. Neurobiol Dis. 37:503–509.
2010.
|
|
15
|
Jones RW: Inflammation and Alzheimer’s
disease. Lancet. 358:436–437. 2001.
|
|
16
|
Ekdahl CT, Kokaia Z and Lindvall O: Brain
inflammation and adult neurogenesis: the dual role of microglia.
Neuroscience. 158:1021–1029. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim YS and Joh TH: Microglia, major player
in the brain inflammation: their roles in the pathogenesis of
Parkinson’s disease. Exp Mol Med. 38:333–347. 2006.PubMed/NCBI
|
|
18
|
Min KJ, Yang MS, Kim SU, Jou I and Joe EH:
Astrocytes induce hemeoxygenase-1 expression in microglia: a
feasible mechanism for preventing excessive brain inflammation. J
Neurosci. 26:1880–1887. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jayasooriya RG, Kang CH, Seo MJ, Choi YH,
Jeong YK and Kim GY: Exopolysaccharide of Laetiporus
sulphureus var miniatus downregulates LPS-induced
production of NO, PGE(2), and TNF-alpha in BV2 microglia cells via
suppression of the NF-kappaB pathway. Food Chem Toxicol.
49:2758–2764. 2011.PubMed/NCBI
|
|
20
|
Ha SK, Moon E and Kim SY: Chrysin
suppresses LPS-stimulated proinflammatory responses by blocking
NF-kappaB and JNK activations in microglia cells. Neurosci Lett.
485:143–147. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wilms H, Rosenstiel P, Sievers J, Deuschl
G, Zecca L and Lucius R: Activation of microglia by human
neuromelanin is NF-kappaB dependent and involves p38
mitogen-activated protein kinase: implications for Parkinson’s
disease. FASEB J. 17:500–502. 2003.PubMed/NCBI
|
|
22
|
Kaltschmidt B, Uherek M, Volk B, Baeuerle
PA and Kaltschmidt C: Transcription factor NF-kappaB is activated
in primary neurons by amyloid beta peptides and in neurons
surrounding early plaques from patients with Alzheimer disease.
Proc Natl Acad Sci USA. 94:2642–2647. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Choi KC, Lee YH, Jung MG, et al: Gallic
acid suppresses lipopolysaccharide-induced nuclear factor-kappaB
signaling by preventing RelA acetylation in A549 lung cancer cells.
Mol Cancer Res. 7:2011–2021. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Duclot F, Jacquet C, Gongora C and Maurice
T: Alteration of working memory but not in anxiety or stress
response in p300/CBP associated factor (PCAF) histone acetylase
knockout mice bred on a C57BL/6 background. Neurosci Lett.
475:179–183. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Maurice T, Duclot F, Meunier J, et al:
Altered memory capacities and response to stress in
p300/CBP-associated factor (PCAF) histone acetylase knockout mice.
Neuropsychopharmacology. 33:1584–1602. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yoon HG, Chan DW, Huang ZQ, et al:
Purification and functional characterization of the human N-CoR
complex: the roles of HDAC3, TBL1 and TBLR1. EMBO J. 22:1336–1346.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kusio-Kobialka M, Dudka-Ruszkowska W,
Ghizzoni M, et al: Inhibition of PCAF by anacardic acid derivative
leads to apoptosis and breaks resistance to DNA damage in
BCR-ABL-expressing cells. Anticancer Agents Med Chem. Nov
13–2012.(Epub ahead of print).
|
|
28
|
Harry GJ and Kraft AD: Neuroinflammation
and microglia: considerations and approaches for neurotoxicity
assessment. Expert Opin Drug Metab Toxicol. 4:1265–1277. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Block ML, Zecca L and Hong JS:
Microglia-mediated neurotoxicity: uncovering the molecular
mechanisms. Nat Rev Neurosci. 8:57–69. 2007. View Article : Google Scholar : PubMed/NCBI
|
